AXA Framlington Emerging Markets


Print  Refer a friend


Click to buy this fund now

AXA FRAMLINGTON EMERGING MARKETS
INITIAL CHARGE DISCOUNT REDUCED INITIAL CHARGE
5.25% 4.75% 0.50%

OUR VIEW:

The fund has outperformed the index in each of the last three years, so it has the dual attraction of experienced management and outstanding performance. It is managed by William Calvert, who has been fulfilling this role with Framlington since 1997. The fund can choose from all emerging markets, and the manager takes care to avoid areas where the downside potential is too great, whether at a stock or country level, a defensive approach which has attractions in these higher risk markets. 


RISK AND YOUR PORTFOLIO:

This is undoubtedly a higher risk fund, but one that is well diversified. Providing that you are comfortable with such higher risk investments, you should probably regard 10% of your portfolio as the minimum that should be invested into emerging markets. If this will be your first foray into emerging markets, you could begin with just 5%, and top-up on weakness, or simply invest monthly. We discuss this in more detail in our separate emerging markets research.  


ABOUT THE FUND:

To achieve capital growth through investment in companies which are incorporated, have their headquarters, or have their principal operations in countries which are, in the Manager's opinion, developing countries.


FUND FACTS:
LAUNCHED FUND SIZE ANNUAL CHARGE FUND MANAGER
31/12/1992 £114.1 million 1.50% William Calvert

FUND PERFORMANCE: To 31st March 2009
0-12m 12-24m 24-36m 36-48m 48-60m
-33.21% +23.02% +8.05% +65.79% +14.77%

 

Print  Refer a friend

 

Register for alerts




“What another excellent guide! I do think it gets better and better”, Mr Brennan London read more

 




Dennehy Weller & Co Ltd, 3 High Street, Chislehurst, Kent, BR7 5AB. Tel: 020 8467 1666. Authorised and regulated by the Financial Services Authority (http://www.fsa.gov.uk/register/home.do). FSA Registration No: 114360. Registered in England & Wales, No. 1476316. Registered Office: 303 High Street, Orpington, Kent, BR6 0NN. The information contained within this site is subject to the UK regulatory regime and is therefore targeted primarily at investors based in the UK.